<DOC>
	<DOCNO>NCT01227369</DOCNO>
	<brief_summary>Quality Life ( QoL ) Korean postmenopausal osteoporosis patient bisphosphonate treatment</brief_summary>
	<brief_title>Quality Life ( QoL ) Korean Postmenopausal Osteoporosis Patients With Bisphosphonate Treatment</brief_title>
	<detailed_description>Cross-sectional quality life survey use self-administered OPSAT-QTM questionnaire Korean postmenopausal osteoporosis patient bisphosphonate treatment</detailed_description>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Osteoporosis , Postmenopausal</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<criteria>Who diagnose postmenopausal osteoporosis physician Who receive oral bisphosphonates ( weekly monthly ) least 2 month provide answer OPSATQTM questionnaire Who provide inform consent study participation Do understand content questionnaire</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Bisphosphonates</keyword>
	<keyword>OPSAT-Q</keyword>
</DOC>